Molina Healthcare, Inc. (MOH)

NYSE: MOH · Real-Time Price · USD

198.84

+2.39 (1.22%)

Aug 10, 2026, 4:00 PM EDT - Market closed

Molina Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-7	472	1,179	1,091	792	659
Depreciation & Amortization	168	195	186	171	176	131
Stock-Based Compensation	76	47	116	115	103	72
Other Adjustments	68	40	61	-29	150	34
Change in Receivables	369	-145	-78	-778	-95	-415
Changes in Accounts Payable	146	-221	115	328	55	138
Changes in Accrued Expenses	-128	-132	-40	580	153	471
Changes in Income Taxes Payable	-204	-201	-18	-2	2	7
Changes in Unearned Revenue	11	-51	-367	59	-11	-5
Changes in Other Operating Activities	-134	-539	-510	127	-552	1,027
Operating Cash Flow	365	-535	644	1,662	773	2,119
Operating Cash Flow Growth	-32.03%	-	-61.25%	115.01%	-63.52%	11.64%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-94	-101	-100	-84	-91	-77
Purchases of Investments	-956	-751	-1,132	-1,433	-1,913	-2,713
Proceeds from Sale of Investments	1,363	1,408	1,111	772	1,398	1,329
Cash Acquisitions	-	-245	-344	-3	-134	-129
Other Investing Activities	-25	1	1	4	-50	-63
Investing Cash Flow	288	312	-464	-744	-790	-1,653

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	450	1,938	1,040	-	-	740
Long-Term Debt Repaid	-	-1,100	-300	-	-	-723
Net Long-Term Debt Issued (Repaid)	450	838	740	-	-	17
Repurchase of Common Stock	-515	-1,037	-1,057	-60	-454	-181
Net Common Stock Issued (Repurchased)	-515	-1,037	-1,057	-60	-454	-181
Other Financing Activities	-25	29	-30	2	13	-19
Financing Cash Flow	-152	-170	-347	-58	-441	-183

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	501	-393	-167	860	-458	283

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	271	-636	544	1,578	682	2,042
Free Cash Flow Growth	-36.53%	-	-65.53%	131.38%	-66.60%	11.95%
FCF Margin	0.61%	-1.40%	1.34%	4.63%	2.13%	7.35%
Free Cash Flow Per Share	5.27	-12.02	9.43	27.16	11.66	34.85
Levered Free Cash Flow	208	260	1,185	2,270	524	2,368
Unlevered Free Cash Flow	1.83	-424.14	532.55	2,351	605.96	2,460

SEC Filings: 10-K · 10-Q